Viracta Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	13.13	12.32	36.77	103.55	47.09	18.22
Short-Term Investments	8.01	41.51	54.71	-	-	-
Cash & Short-Term Investments	21.13	53.83	91.49	103.55	47.09	18.22
Cash Growth	-66.52%	-41.16%	-11.65%	119.91%	158.48%	353.92%
Other Receivables	-	0.28	0.91	-	-	-
Receivables	-	0.28	0.91	-	-	-
Prepaid Expenses	0.67	0.86	1.35	1.72	0.11	0.08
Other Current Assets	-	-	0.01	-	-	-
Total Current Assets	21.8	54.96	93.75	105.27	47.2	18.3
Property, Plant & Equipment	0.11	0.46	0.41	0.88	1.03	0.12
Other Long-Term Assets	0.04	1.26	1.83	2.4	0.08	0.03
Total Assets	21.96	56.69	95.99	108.55	48.31	18.44
Accounts Payable	1.82	2.44	2.54	2.9	1.56	1.54
Accrued Expenses	9.85	10.38	7.19	5.8	3.36	0.74
Current Portion of Long-Term Debt	16.91	25.27	-	-	1.03	-
Current Portion of Leases	-	0.28	0.28	0.38	0.33	0.12
Total Current Liabilities	28.58	38.37	10.01	9.08	6.28	2.39
Long-Term Debt	-	-	24.88	4.82	4.16	-
Long-Term Leases	-	-	-	0.28	0.66	-
Total Liabilities	28.58	38.37	34.89	14.18	11.1	2.39
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	288.83	278.79	270.7	254.59	4.71	3.51
Retained Earnings	-295.46	-265.93	-214.87	-165.68	-50.92	-31.9
Comprehensive Income & Other	0.01	0.01	-0.18	-	-	-
Total Common Equity	-6.62	12.87	55.65	88.92	-46.2	-28.38
Shareholders' Equity	-6.62	18.32	61.1	94.37	37.21	16.05
Total Liabilities & Equity	21.96	56.69	95.99	108.55	48.31	18.44
Total Debt	16.91	25.56	25.16	5.48	6.18	0.12
Net Cash (Debt)	4.22	28.27	66.33	98.08	40.91	18.1
Net Cash Growth	-88.76%	-57.38%	-32.37%	139.73%	126.02%	-
Net Cash Per Share	0.11	0.73	1.76	3.08	125.99	7.68
Filing Date Shares Outstanding	39.74	39.27	38.41	37.49	8.1	0.64
Total Common Shares Outstanding	39.74	39.09	38.35	37.42	8.1	0.64
Working Capital	-6.77	16.59	83.74	96.19	40.92	15.91
Book Value Per Share	-0.17	0.33	1.45	2.38	-5.71	-44.13
Tangible Book Value	-6.62	12.87	55.65	88.92	-46.2	-28.38
Tangible Book Value Per Share	-0.17	0.33	1.45	2.38	-5.71	-44.13
Machinery	-	-	-	-	-	0.01

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.